Women using semaglutide should discontinue treatment at least 2 months before a planned pregnancy
For weight management , NICE technology appraisal guidance supports semaglutide 2.4 mg (Wegovy) for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 30 kg/m in exceptional circumstances), as part of a specialist weight management service
They can assess whether an alternative GLP-1 formulation or different medication class may be more suitable for your circumstances
Regarding FDA approvals , Mounjaro is primarily approved for managing type 2 diabetes , although it has shown significant weight loss in studies
A structural basis for amylin receptor phenotype
Birth of the incretin concept The same year Lim and Kosaka published their hypothesis, the Belgian physiologist La Barre attempted to purify secretin with Eugene Still, a colleague at the University of Chicago